# |
PMID |
Sentence |
1 |
21950552
|
Reduced expression of myocardin and serum response factor in the cavernous tissue of diabetic rats.
|
2 |
21950552
|
This study aimed to investigate the expression of myocardin and serum response factor (SRF) in the cavernous tissue of diabetic rats.
|
3 |
21950552
|
Western blot and qRT-PCR were used to determine the protein and mRNA expression levels of myocardin and SRF.
|
4 |
21950552
|
The mRNA and protein expression levels of myocardin and SRF were reduced in the cavernous tissue of diabetic rats compared with the control group (P < 0.001).
|
5 |
21950552
|
It is concluded that diabetes inhibits the mRNA and protein expression of both myocardin and SRF in the cavernous tissue.
|
6 |
21950552
|
Reduced expression of myocardin and serum response factor in the cavernous tissue of diabetic rats.
|
7 |
21950552
|
This study aimed to investigate the expression of myocardin and serum response factor (SRF) in the cavernous tissue of diabetic rats.
|
8 |
21950552
|
Western blot and qRT-PCR were used to determine the protein and mRNA expression levels of myocardin and SRF.
|
9 |
21950552
|
The mRNA and protein expression levels of myocardin and SRF were reduced in the cavernous tissue of diabetic rats compared with the control group (P < 0.001).
|
10 |
21950552
|
It is concluded that diabetes inhibits the mRNA and protein expression of both myocardin and SRF in the cavernous tissue.
|
11 |
21950552
|
Reduced expression of myocardin and serum response factor in the cavernous tissue of diabetic rats.
|
12 |
21950552
|
This study aimed to investigate the expression of myocardin and serum response factor (SRF) in the cavernous tissue of diabetic rats.
|
13 |
21950552
|
Western blot and qRT-PCR were used to determine the protein and mRNA expression levels of myocardin and SRF.
|
14 |
21950552
|
The mRNA and protein expression levels of myocardin and SRF were reduced in the cavernous tissue of diabetic rats compared with the control group (P < 0.001).
|
15 |
21950552
|
It is concluded that diabetes inhibits the mRNA and protein expression of both myocardin and SRF in the cavernous tissue.
|
16 |
21950552
|
Reduced expression of myocardin and serum response factor in the cavernous tissue of diabetic rats.
|
17 |
21950552
|
This study aimed to investigate the expression of myocardin and serum response factor (SRF) in the cavernous tissue of diabetic rats.
|
18 |
21950552
|
Western blot and qRT-PCR were used to determine the protein and mRNA expression levels of myocardin and SRF.
|
19 |
21950552
|
The mRNA and protein expression levels of myocardin and SRF were reduced in the cavernous tissue of diabetic rats compared with the control group (P < 0.001).
|
20 |
21950552
|
It is concluded that diabetes inhibits the mRNA and protein expression of both myocardin and SRF in the cavernous tissue.
|
21 |
21950552
|
Reduced expression of myocardin and serum response factor in the cavernous tissue of diabetic rats.
|
22 |
21950552
|
This study aimed to investigate the expression of myocardin and serum response factor (SRF) in the cavernous tissue of diabetic rats.
|
23 |
21950552
|
Western blot and qRT-PCR were used to determine the protein and mRNA expression levels of myocardin and SRF.
|
24 |
21950552
|
The mRNA and protein expression levels of myocardin and SRF were reduced in the cavernous tissue of diabetic rats compared with the control group (P < 0.001).
|
25 |
21950552
|
It is concluded that diabetes inhibits the mRNA and protein expression of both myocardin and SRF in the cavernous tissue.
|
26 |
22592762
|
The cavernous tissue segments were subjected to quantitative real-time polymerase chain reaction to determine the expressions of smooth muscle α-actin (SMA), SM myosin heavy chain (SMMHC), smoothelin, calponin and myocardin.
|
27 |
22592762
|
Cell contractility in vitro and western blot analysis of SMA and SMMHC in the cavernous tissues and cells were determined.
|
28 |
22592762
|
Compared with the control group (n=8) and the diabetes mellitus group (n=5), the expressions of SMA, calponin, SMMHC, smoothelin and myocardin mRNA were decreased in the cavernous tissues in rats of the diabetic erectile dysfunction group (n=15; P=0.001 and 0.02, P=0.014 and 0.012, both P<0.001, P=0.005 and <0.001, P=0.003 and 0.035, respectively).
|
29 |
22592762
|
The levels of SMA and SMMHC proteins showed a significant decrease in cavernous tissues and cultured cells in rats of the diabetic erectile dysfunction group.
|
30 |
23178076
|
SMA expression is regulated by transforming growth factor (TGF)-β1 and cell contact disruption, through signaling events targeting the serum response factor-myocardin-related transcription factor (MRTF) complex.
|
31 |
23178076
|
When co-expressed, it inhibited the stimulatory effects of MRTF-A, MRTF-B or the constitutive active forms of RhoA, Rac1, or Cdc42 on the SMA promoter.
|